162 related articles for article (PubMed ID: 11765027)
1. Serum and urine concentrations of flunitrazepam and metabolites, after a single oral dose, by immunoassay and GC-MS.
Snyder H; Schwenzer KS; Pearlman R; McNally AJ; Tsilimidos M; Salamone SJ; Brenneisen R; ElSohly MA; Feng S
J Anal Toxicol; 2001; 25(8):699-704. PubMed ID: 11765027
[TBL] [Abstract][Full Text] [Related]
2. Flunitrazepam excretion patterns using the Abuscreen OnTrak and OnLine immunoassays: comparison with GC-MS.
Salamone SJ; Honasoge S; Brenner C; McNally AJ; Passarelli J; Goc-Szkutnicka K; Brenneisen R; elSohly MA; Feng S
J Anal Toxicol; 1997 Sep; 21(5):341-5. PubMed ID: 9288585
[TBL] [Abstract][Full Text] [Related]
3. New fluorescence polarization immunoassays for analysis of barbiturates and benzodiazepines in serum and urine: performance characteristics.
Schwenzer KS; Pearlman R; Tsilimidos M; Salamone SJ; Cannon RC; Wong SH; Gock SB; Jentzen JJ
J Anal Toxicol; 2000; 24(8):726-32. PubMed ID: 11110029
[TBL] [Abstract][Full Text] [Related]
4. GC-MS determination of flunitrazepam and its major metabolite in whole blood and plasma.
ElSohly MA; Feng S; Salamone SJ; Brenneisen R
J Anal Toxicol; 1999 Oct; 23(6):486-9. PubMed ID: 10517555
[TBL] [Abstract][Full Text] [Related]
5. A sensitive GC-MS procedure for the analysis of flunitrazepam and its metabolites in urine.
elSohly MA; Feng S; Salamone SJ; Wu R
J Anal Toxicol; 1997 Sep; 21(5):335-40. PubMed ID: 9288584
[TBL] [Abstract][Full Text] [Related]
6. Identification of urinary benzodiazepines and their metabolites: comparison of automated HPLC and GC-MS after immunoassay screening of clinical specimens.
Valentine JL; Middleton R; Sparks C
J Anal Toxicol; 1996 Oct; 20(6):416-24. PubMed ID: 8889678
[TBL] [Abstract][Full Text] [Related]
7. A sensitive immunoassay for flunitrazepam and metabolites.
Walshe K; Barrett AM; Kavanagh PV; McNamara SM; Moran C; Shattock AG
J Anal Toxicol; 2000; 24(4):296-9. PubMed ID: 10872578
[TBL] [Abstract][Full Text] [Related]
8. Elimination of 7-aminoflunitrazepam and flunitrazepam in urine after a single dose of Rohypnol.
Negrusz A; Moore CM; Stockham TL; Poiser KR; Kern JL; Palaparthy R; Le NL; Janicak PG; Levy NA
J Forensic Sci; 2000 Sep; 45(5):1031-40. PubMed ID: 11005178
[TBL] [Abstract][Full Text] [Related]
9. Improved screen and confirmation test of 7-aminoflunitrazepam in urine specimens for monitoring flunitrazepam (Rohypnol) exposure.
Wang PH; Liu C; Tsay WI; Li JH; Liu RH; Wu TG; Cheng WJ; Lin DL; Huang TY; Chen CH
J Anal Toxicol; 2002 Oct; 26(7):411-8. PubMed ID: 12422994
[TBL] [Abstract][Full Text] [Related]
10. Determination of flunitrazepam and its main metabolites in serum and urine by HPLC after mixed-mode solid-phase extraction.
Deinl I; Mahr G; von Meyer L
J Anal Toxicol; 1998; 22(3):197-202. PubMed ID: 9602935
[TBL] [Abstract][Full Text] [Related]
11. Highly sensitive micro-plate enzyme immunoassay screening and NCI-GC-MS confirmation of flunitrazepam and its major metabolite 7-aminoflunitrazepam in hair.
Negrusz A; Moore C; Deitermann D; Lewis D; Kaleciak K; Kronstrand R; Feeley B; Niedbala RS
J Anal Toxicol; 1999 Oct; 23(6):429-35. PubMed ID: 10517547
[TBL] [Abstract][Full Text] [Related]
12. Extraction and analysis of flunitrazepam/7-aminoflunitrazepam in blood and urine by LC-PDA and GC-MS using butyl SPE columns.
Hackett J; Elian AA
Forensic Sci Int; 2006 Mar; 157(2-3):156-62. PubMed ID: 15955650
[TBL] [Abstract][Full Text] [Related]
13. Urinary detection times and excretion patterns of flunitrazepam and its metabolites after a single oral dose.
Forsman M; Nyström I; Roman M; Berglund L; Ahlner J; Kronstrand R
J Anal Toxicol; 2009 Oct; 33(8):491-501. PubMed ID: 19874658
[TBL] [Abstract][Full Text] [Related]
14. Performance characteristics of 7-aminoflunitrazepam specific enzyme-linked immunosorbent assays.
Lin DL; Yin RM; Chen CH; Chen YL; Liu RH
J Anal Toxicol; 2005 Oct; 29(7):718-23. PubMed ID: 16419407
[TBL] [Abstract][Full Text] [Related]
15. Solid-phase microextraction and GC-ECD of benzophenones for detection of benzodiazepines in urine.
Guan F; Seno H; Ishii A; Watanabe K; Kumazawa T; Hattori H; Suzuki O
J Anal Toxicol; 1999; 23(1):54-61. PubMed ID: 10022210
[TBL] [Abstract][Full Text] [Related]
16. Automated solid-phase extraction and liquid chromatography-electrospray ionization-mass spectrometry for the determination of flunitrazepam and its metabolites in human urine and plasma samples.
Jourdil N; Bessard J; Vincent F; Eysseric H; Bessard G
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 May; 788(2):207-19. PubMed ID: 12705961
[TBL] [Abstract][Full Text] [Related]
17. Characterization and evaluation of two-dimensional microfluidic chip-HPLC coupled to tandem mass spectrometry for quantitative analysis of 7-aminoflunitrazepam in human urine.
Bai HY; Lin SL; Chan SA; Fuh MR
Analyst; 2010 Oct; 135(10):2737-42. PubMed ID: 20820494
[TBL] [Abstract][Full Text] [Related]
18. Benzodiazepines in Miami-Dade County, Florida driving under the influence (DUI) cases (1995-1998) with emphasis on Rohypnol: GC-MS confirmation, patterns of use, psychomotor impairment, and results of Florida legislation.
Raymon LP; Steele BW; Walls HC
J Anal Toxicol; 1999 Oct; 23(6):490-9. PubMed ID: 10517556
[TBL] [Abstract][Full Text] [Related]
19. Detection of flunitrazepam and 7-aminoflunitrazepam in oral fluid after controlled administration of rohypnol.
Samyn N; De Boeck G; Cirimele V; Verstraete A; Kintz P
J Anal Toxicol; 2002; 26(4):211-5. PubMed ID: 12054361
[TBL] [Abstract][Full Text] [Related]
20. Toxicological detection of pholcodine and its metabolites in urine and hair using radio immunoassay, fluorescence polarisation immunoassay, enzyme immunoassay, and gas chromatography-mass spectrometry.
Maurer HH; Fritz CF
Int J Legal Med; 1990 Dec; 104(1):43-6. PubMed ID: 11453092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
